Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine
- 23 December 1998
- Vol. 17 (2) , 172-181
- https://doi.org/10.1016/s0264-410x(98)00155-8
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The expanding universe of T-cell subsets: Th1, Th2 and morePublished by Elsevier ,1999
- A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzeesVaccine, 1994
- Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesisVaccine, 1994
- Attenuated temperature-sensitive respiratory syncytial virus mutants generated by cold adaptationVirus Research, 1994
- An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccinesVirus Research, 1994
- A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSVVaccine, 1993
- Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenonVaccine, 1993
- Experimental respiratory syncytial virus pneumonia in cebus monkeysJournal of Medical Virology, 1978
- Evaluation of a live, attenuated respiratory syncytial virus vaccine in infantsThe Journal of Pediatrics, 1976
- Low-temperature-grown RS virus in adult volunteersPublished by American Medical Association (AMA) ,1968